These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30683688)

  • 1. Reciprocal regulation of STING and TCR signaling by mTORC1 for T-cell activation and function.
    Imanishi T; Unno M; Kobayashi W; Yoneda N; Matsuda S; Ikeda K; Hoshii T; Hirao A; Miyake K; Barber GN; Arita M; Ishii KJ; Akira S; Saito T
    Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30683688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
    Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
    Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.
    Li T; Cheng H; Yuan H; Xu Q; Shu C; Zhang Y; Xu P; Tan J; Rui Y; Li P; Tan X
    Sci Rep; 2016 Jan; 6():19049. PubMed ID: 26754564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T
    Benoit-Lizon I; Jacquin E; Rivera Vargas T; Richard C; Roussey A; Dal Zuffo L; Martin T; Melis A; Vinokurova D; Shahoei SH; Baeza Garcia A; Pignol C; Giorgiutti S; Carapito R; Boidot R; Végran F; Flavell RA; Ryffel B; Nelson ER; Soulas-Sprauel P; Lawrence T; Apetoh L
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
    Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
    Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
    Johnson BM; Uchimura T; Gallovic MD; Thamilarasan M; Chou WC; Gibson SA; Deng M; Tam JW; Batty CJ; Williams J; Matsushima GK; Bachelder EM; Ainslie KM; Markovic-Plese S; Ting JP
    J Immunol; 2021 May; 206(9):2015-2028. PubMed ID: 33820855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages.
    Li Y; James SJ; Wyllie DH; Wynne C; Czibula A; Bukhari A; Pye K; Bte Mustafah SM; Fajka-Boja R; Szabo E; Angyal A; Hegedus Z; Kovacs L; Hill AVS; Jefferies CA; Wilson HL; Yongliang Z; Kiss-Toth E
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16479-16488. PubMed ID: 31346090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
    Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
    FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.
    Nagata M; Kosaka A; Yajima Y; Yasuda S; Ohara M; Ohara K; Harabuchi S; Hayashi R; Funakoshi H; Ueda J; Kumai T; Nagato T; Oikawa K; Harabuchi Y; Esteban C; Ohkuri T; Kobayashi H
    Cancer Immunol Immunother; 2021 Aug; 70(8):2301-2312. PubMed ID: 33507344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cGAMP via the STING pathway in modulating germinal center responses and CD4 T cell differentiation.
    Yoon M; Choi Y; Wi T; Choi YS; Choi J
    Front Immunol; 2024; 15():1340001. PubMed ID: 38680492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic innate immune activation of TBK1 suppresses mTORC1 activity and dysregulates cellular metabolism.
    Hasan M; Gonugunta VK; Dobbs N; Ali A; Palchik G; Calvaruso MA; DeBerardinis RJ; Yan N
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):746-751. PubMed ID: 28069950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
    Berthelot JM; Lioté F; Maugars Y; Sibilia J
    Front Immunol; 2020; 11():607069. PubMed ID: 33335532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 ubiquitin ligase Peli1 regulates the metabolic actions of mTORC1 to suppress antitumor T cell responses.
    Ko CJ; Zhang L; Jie Z; Zhu L; Zhou X; Xie X; Gao T; Yang JY; Cheng X; Sun SC
    EMBO J; 2021 Jan; 40(2):e104532. PubMed ID: 33215753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STING trafficking activates MAPK-CREB signaling to trigger regulatory T cell differentiation.
    Lin W; Szabo C; Liu T; Tao H; Wu X; Wu J
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2320709121. PubMed ID: 38985760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-elicited Cation Fluxes Promote Volume-regulated Anion Channel LRRC8/VRAC Transport cGAMP for Antitumor Immunity.
    Wang L; Cao L; Li Z; Shao Z; Chen X; Huang Z; He X; Zheng J; Liu L; Jia XM; Xiao H
    J Immunol; 2024 Aug; 213(3):347-361. PubMed ID: 38847616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific activation thresholds of CD8+ T cells are independent of IFN-I-mediated partial lymphocyte activation.
    Wijesundara DK; Kumar S; Alsharifi M; Müllbacher A; Regner M
    Int Immunol; 2010 Sep; 22(9):757-67. PubMed ID: 20682547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
    Cheng N; Watkins-Schulz R; Junkins RD; David CN; Johnson BM; Montgomery SA; Peine KJ; Darr DB; Yuan H; McKinnon KP; Liu Q; Miao L; Huang L; Bachelder EM; Ainslie KM; Ting JP
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel transcript isoform of STING that sequesters cGAMP and dominantly inhibits innate nucleic acid sensing.
    Wang PH; Fung SY; Gao WW; Deng JJ; Cheng Y; Chaudhary V; Yuen KS; Ho TH; Chan CP; Zhang Y; Kok KH; Yang W; Chan CP; Jin DY
    Nucleic Acids Res; 2018 May; 46(8):4054-4071. PubMed ID: 29547894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.